Which selective serotonin reuptake inhibitor (SSRI) has the lowest risk of overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Sertraline has the lowest risk of overdose among SSRIs

Based on the available evidence, sertraline is the safest SSRI in overdose, followed by fluoxetine, fluvoxamine, and paroxetine, while citalopram should be avoided in patients at risk of overdose due to cardiac toxicity.

Safety Profile in Overdose

The research consistently demonstrates that SSRIs as a class are remarkably safe in overdose compared to tricyclic antidepressants, with very few fatalities reported when taken alone 1. However, important differences exist between individual SSRIs:

Sertraline: The Safest Option

  • Sertraline demonstrated the lowest likelihood of overdose-related hospital admissions (likelihood ratio 0.79,95% CI 0.63-0.99) 2
  • In a recent 2026 study of over 750,000 patients, sertraline showed the lowest incidence of opioid overdose when co-prescribed with oxycodone (10.8 per 1,000 person-years), with all other SSRIs showing 22-26% higher hazard ratios 3
  • Fewer patients discontinued sertraline due to adverse effects compared to other SSRIs 4

Citalopram: The Exception to SSRI Safety

Citalopram is the most dangerous SSRI in overdose and should be specifically avoided in patients at risk:

  • Citalopram showed significantly prolonged QTc intervals (median 450 msec) compared to all other SSRIs 5
  • 68% of citalopram overdoses resulted in QTc >440 msec, with an adjusted odds ratio of 5.11 compared to sertraline 5
  • Six fatalities following citalopram overdoses have been reported, raising specific concerns 4
  • Cardiac monitoring is recommended in citalopram overdose, particularly with large ingestions 5

Other SSRIs: Intermediate Safety

  • Fluoxetine, fluvoxamine, and paroxetine show similar overdose safety profiles 1
  • No apparent differences in overdose mortality among these three agents 1
  • Moderate overdoses (up to 30 times daily dose) typically cause only minor symptoms 1

Clinical Implications

When to Choose Sertraline

  • Patients with suicidal ideation or previous overdose attempts
  • Patients with depression and comorbid substance use disorders
  • Situations where overdose risk cannot be adequately assessed
  • Patients requiring concomitant opioid therapy

Key Overdose Characteristics

At therapeutic to moderate overdoses, SSRIs typically cause:

  • Drowsiness, tremor, nausea, and vomiting 1
  • Serotonin syndrome (occurs in 14% of SSRI overdoses) 5

At very high doses (>75 times daily dose):

  • Seizures (1.9% incidence)
  • ECG changes
  • Decreased consciousness (coma in 2.4%) 5

Critical Caveat

Almost all SSRI-related fatalities involve co-ingestion of alcohol or other drugs 1. The safety profile changes dramatically with polysubstance overdose, making patient education about avoiding alcohol and other CNS depressants essential.

Practical Algorithm

  1. First-line for overdose-prone patients: Sertraline
  2. Acceptable alternatives: Fluoxetine, fluvoxamine, paroxetine
  3. Avoid entirely in overdose-risk patients: Citalopram (and escitalopram by extension)
  4. If citalopram overdose occurs: Obtain ECG and cardiac monitoring

The evidence strongly supports sertraline as the optimal choice when overdose risk is a clinical consideration, with citalopram representing a clear contraindication in this population 5, 2, 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.